March 18, 2022
900 Cottage Grove Road
Bloomfield, Connecticut 06002
Dear Fellow Shareholders:
2021 was a strong year for our company, and we are extremely proud of our Cigna team who, with great resolve
and commitment, delivered on Cigna’s mission to improve the health, well-being, and peace of mind of those we serve. As we all navigated a full second year of the COVID-19 pandemic, our team hosted vaccination clinics, supported access to testing
and treatment, and volunteered at mass walk-in sites as part of our Community of Immunity program. At the same time, we delivered strong overall 2021 results, as we continued to innovate and advance our
work to make healthcare more affordable, predictable, and simple.
Financial Performance
Cigna delivered on our overall financial goals for fiscal year 2021:
•
|
Grew both revenue and adjusted revenue* by 9% to $174 billion;
|
•
|
Achieved shareholders net income per share of $15.73 and adjusted income from operations, per share* of $20.47, representing
|
11% growth; and
•
|
Returned over $9 billion to shareholders via dividends and share repurchase, a significant increase over 2020.
|
We also sharpened our focus on our global health services portfolio and announced the sale of our life,
accident, and supplemental benefits businesses in seven international markets to Chubb. Subject to applicable regulatory approvals and customary closing conditions, we expect to complete this transaction in the second quarter of 2022.
Looking ahead, 2022 will be another year of attractive growth for our company, reinforcing the strength of
our businesses.
Advancing Our Strategy
We made meaningful progress on our strategy through our powerful combination of growth platforms: Evernorth
and Cigna Healthcare.
Our health services business successfully marked its first full-year of operations under the Evernorth brand
and grew adjusted revenue by 14% in 2021. Evernorth brings together pharmacy, care, benefits and intelligence services, along with deep expertise and the flexibility to partner across the health care system. This platform is well-positioned to
take advantage of the rapidly changing healthcare landscape. For example, Evernorth will continue to grow from the significant demand for more mental health services, as well as rapidly changing access to care models. Evernorth is continuing to
expand virtual care services leveraging MDLIVE, a telehealth acquisition made early in 2021, and through expansion of our behavioral care networks. Today, we offer virtual care options for behavioral health, and also for primary care and
wellness, urgent, and dermatology services.
In our Cigna Healthcare portfolio, including our U.S. Commercial, U.S. Government, and International Health
businesses, in total we delivered attractive growth and ended the year with 17.1 million total medical customers. Overall, Cigna Healthcare supported and delivered for our customers, clients, and partners through a challenging year, and is
well-positioned to both grow membership and focus on margin expansion in 2022. Additionally, Cigna Healthcare will partner and leverage our Evernorth innovations. For example, we’re continuing to expand digital experiences that help engage
customers and create better health outcomes, improved customer experience and lower total cost of care. A recent approach we developed for patients diagnosed with orthopedic and musculoskeletal conditions provides highly personalized and
actionable information to guide their choices and support improved health outcomes and affordability.
Making Strides on Environmental, Social, and Governance (ESG)
We made significant advancements on ESG areas of focus that are important to us as a company and to our
stakeholders, and align with our mission. With the leadership of our Diversity, Equity, and Inclusion (DEI) Council, we built on our longstanding efforts to promote health equity in at-risk populations through increased community grants,
partnerships, and other efforts. Our new publicly available Diversity Scorecard tangibly reflects our commitment to DEI, and how we are holding ourselves accountable for progress.
We are proud to remain a leader in corporate sustainability, and our efforts have been recognized by a number
of prominent organizations, including the Dow Jones Sustainability Indices for a fifth consecutive year.
This year, we also focused on refreshing our Board to ensure we have the skills necessary to help the company
continue to grow and thrive long-term. We were pleased to add George Kurian, CEO of NetApp, Inc. and Neesha Hathi, Chief Digital Officer of The Charles Schwab Corporation to complement the diversity of experience on our Board. Both George and
Neesha bring strong customer engagement experience and business leadership that will serve us well. We would also like to take this opportunity to again thank Isaiah “Ike” Harris, Jr., who retired from the Board at the end of the year. During his
tenure, we benefited from Ike’s many contributions and counsel, and share his optimism for our future. With Ike’s retirement, Eric Wiseman was appointed to Lead Independent Director, and looks forward to continuing to serve and deliver on our
mission.
Annual Meeting of Shareholders
On behalf of the Cigna Corporation Board of Directors, we invite you to attend our 2022 Annual Meeting of
Shareholders, to be held April 27, 2022. The attached Notice of 2022 Annual Meeting of Shareholders and Proxy Statement contains important information about the business to be conducted at the Annual Meeting.
We look forward to continuing to serve our customers, patients, and clients, and delivering attractive value
creation and sustained growth in the years ahead. On behalf of our more than 70,000 employees around the world, and the entire Board, we thank you for your support and investment in Cigna.
Sincerely,
/s/ David M. Cordani
|
|
|
/s/Eric C. Wiseman
|
David M. Cordani
|
|
|
Eric C. Wiseman
|
Chairman and Chief Executive Officer
|
|
|
Lead Independent Director
|
*
|
Consolidated adjusted revenues and adjusted income from operations per share are non-GAAP measures. See Annex A to
the Proxy Statement.
|